Disclosures for "Identifying Digital Biomarkers for the Self-Monitoring of Patients Living with Generalized Myasthenia gravis: a Proof of Concept")
-
Pascal Laforet has nothing to disclose.
-
David Orlikowski has nothing to disclose.
-
Prof. NICOLAS has nothing to disclose.
-
The institution of Prof. Prigent has received research support from VLM - Patients association for lysosomial diseases. The institution of Prof. Prigent has received research support from ADEP Assitance.
-
Dr. Berling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adscientiam. Dr. Berling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche.
-
-
Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
-
Dr. Moreira has received personal compensation for serving as an employee of Ad Scientiam.
-
Mrs. Narcy has received personal compensation for serving as an employee of Ad Scientiam.
-
Dr. Plaud has received personal compensation for serving as an employee of Ad Scientiam.
-
Mrs. Touré Cuq has received personal compensation for serving as an employee of Ad Scientiam .
-
Dr. Keller has received personal compensation for serving as an employee of Alexion. Dr. Keller has stock in Alexion, Roche, Novartis, Celgene, Abbvie, Merck, Ionis, Sanofie, Organon, MSD.
-
Mr. Werneburg has received personal compensation for serving as an employee of Alexion.
-
Dr. Aras has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.
-
Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.